Balgopal Commercial [BALGOPAL] vs Authum Investment [AIIL] Detailed Stock Comparison
Balgopal Commercial
BSE
Loading...
Authum Investment
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Balgopal Commercial wins in 5 metrics, Authum Investment wins in 12 metrics, with 0 ties. Authum Investment appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Balgopal Commercial | Authum Investment | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 139.04 | 13.26 | Authum Investment |
| Price-to-Book Ratio | 8.70 | 3.68 | Authum Investment |
| Debt-to-Equity Ratio | 0.11 | 7.18 | Balgopal Commercial |
| PEG Ratio | -2.22 | -0.95 | Balgopal Commercial |
| EV/EBITDA | 74.96 | 12.11 | Authum Investment |
| Profit Margin (TTM) | 63.48% | 93.88% | Authum Investment |
| Operating Margin (TTM) | 439.51% | 96.55% | Balgopal Commercial |
| EBITDA Margin (TTM) | 439.51% | 96.55% | Balgopal Commercial |
| Return on Equity | 11.12% | 28.87% | Authum Investment |
| Return on Assets (TTM) | 9.50% | 26.36% | Authum Investment |
| Free Cash Flow (TTM) | $-68.66M | $2.53B | Authum Investment |
| Dividend Yield | N/A | 0.06% | N/A |
| 1-Year Return | 305.04% | 77.86% | Balgopal Commercial |
| Price-to-Sales Ratio (TTM) | 328.07 | 12.45 | Authum Investment |
| Enterprise Value | $5.10B | $548.85B | Authum Investment |
| EV/Revenue Ratio | 329.58 | 12.61 | Authum Investment |
| Gross Profit Margin (TTM) | N/A | 97.25% | N/A |
| Revenue per Share (TTM) | $1 | $256 | Authum Investment |
| Earnings per Share (Diluted) | $1.87 | $240.61 | Authum Investment |
| Beta (Stock Volatility) | N/A | -0.82 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Balgopal Commercial vs Authum Investment Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Balgopal Commercial | -4.99% | 11.46% | 16.33% | 32.62% | 66.74% | 107.30% |
| Authum Investment | 1.43% | 6.55% | 4.98% | 19.96% | 111.74% | 69.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Balgopal Commercial | 305.04% | 902.75% | 7,164.20% | 7,164.20% | 7,164.20% | 7,164.20% |
| Authum Investment | 77.86% | 275.18% | 275.18% | 275.18% | 275.18% | 275.18% |
News Based Sentiment: Balgopal Commercial vs Authum Investment
Balgopal Commercial
News based Sentiment: NEGATIVE
The sole news item this month was a negative risk assessment from MarketsMojo, categorizing Balgopal Commercial as 'risky' alongside JP Associates. This directly impacts investor perception and suggests potential challenges for the company, making it a significant development despite being the only one reported.
Authum Investment
News based Sentiment: POSITIVE
October was a significant month for Authum Investment & Infrastructure Ltd. due to the combination of impressive financial results, a strategic move into the pharmaceutical sector, and continued positive sentiment from analysts and institutional investors. These developments collectively strengthen the investment case and suggest a positive trajectory for the company.
Performance & Financial Health Analysis: Balgopal Commercial vs Authum Investment
| Metric | BALGOPAL | AIIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹5.08B | ₹542.19B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 16,055 | 247,963 |
| 90 Day Avg. Volume | 11,049 | 219,497 |
| Last Close | ₹242.95 | ₹3,250.10 |
| 52 Week Range | ₹102.70 - ₹272.95 | ₹1,325.50 - ₹3,295.00 |
| % from 52W High | -10.99% | -1.36% |
| All-Time High | ₹272.95 (Oct 06, 2025) | ₹3,295.00 (Sep 16, 2025) |
| % from All-Time High | -10.99% | -1.36% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -1.00% | -0.15% |
| Quarterly Earnings Growth | -1.00% | -0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.63% | 0.94% |
| Operating Margin (TTM) | 4.40% | 0.97% |
| Return on Equity (TTM) | 0.11% | 0.29% |
| Debt to Equity (MRQ) | 0.11 | 7.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹29.89 | ₹866.73 |
| Cash per Share (MRQ) | ₹1.92 | ₹21.74 |
| Operating Cash Flow (TTM) | ₹2.27M | ₹70.10B |
| Levered Free Cash Flow (TTM) | ₹62.94M | ₹42.41B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.06% |
| Last 12-Month Dividend | N/A | ₹1.50 |
Valuation & Enterprise Metrics Analysis: Balgopal Commercial vs Authum Investment
| Metric | BALGOPAL | AIIL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 139.04 | 13.26 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -2.22 | -0.95 |
| Price to Sales (TTM) | 328.07 | 12.45 |
| Price to Book (MRQ) | 8.70 | 3.68 |
| Market Capitalization | ||
| Market Capitalization | ₹5.08B | ₹542.19B |
| Enterprise Value | ₹5.10B | ₹548.85B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 329.58 | 12.61 |
| Enterprise to EBITDA | 74.96 | 12.11 |
| Risk & Other Metrics | ||
| Beta | N/A | -0.82 |
| Book Value per Share (MRQ) | ₹29.89 | ₹866.73 |
Financial Statements Comparison: Balgopal Commercial vs Authum Investment
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BALGOPAL | AIIL |
|---|---|---|
| Revenue/Sales | ₹0 | ₹12.15B |
| Cost of Goods Sold | ₹791,070 | ₹334.70M |
| Gross Profit | ₹-791,070 | ₹11.82B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-3.21M | ₹11.34B |
| EBITDA | ₹20.27M | ₹11.37B |
| Pre-Tax Income | ₹20.27M | ₹11.44B |
| Income Tax | ₹3.61M | ₹2.01B |
| Net Income (Profit) | ₹16.66M | ₹9.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BALGOPAL | AIIL |
|---|---|---|
| Cash & Equivalents | ₹36.42M | ₹1.08B |
| Total Current Assets | ₹245.87M | ₹32.75B |
| Total Current Liabilities | ₹72.33M | ₹10.38B |
| Long-Term Debt | ₹14.37M | ₹3.60B |
| Total Shareholders Equity | ₹565.99M | ₹146.89B |
| Retained Earnings | ₹168.54M | ₹28.29B |
| Property, Plant & Equipment | N/A | ₹21.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BALGOPAL | AIIL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BALGOPAL | AIIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 16,055 | 247,963 |
| Average Daily Volume (90 Day) | 11,049 | 219,497 |
| Shares Outstanding | 19.01M | 169.85M |
| Float Shares | N/A | 33.92M |
| % Held by Insiders | 0.66% | 0.84% |
| % Held by Institutions | 0.00% | 0.06% |
Dividend Analysis & Yield Comparison: Balgopal Commercial vs Authum Investment
| Metric | BALGOPAL | AIIL |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.50 |
| Last 12-Month Dividend Yield | N/A | 0.06% |
| 3-Year Avg Annual Dividend | N/A | ₹0.50 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | N/A | ₹1.50 |
| Ex-Dividend Date | N/A | May 16, 2025 |